We have previously demonstrated that human heat shock protein 90 (HSP90), an intracellular self protein, is the target of cellular and humoral autoimmune responses in patients with carotid atherosclerosis. In this study, we evaluated in vitro whether oxidative stress, a feature of atherosclerotic plaque, alters HSP90 expression in endothelial cells, thus inducing surface localization of this molecule and whether the antioxidant compound 7,8‐dihydroxy‐4‐methylcoumarin (7,8‐DHMC) is able to prevent oxidative stress‐induced alterations of HSP90 localization. By the use of flow cytometry, immunofluorescence, enzyme‐linked immunosorbent assay, and semiquantitative reverse‐transcription polymerase chain reaction, we demonstrated that exposure of human umbilical vein endothelial cells (HUVEC) to the prooxidant compound H2O2 upregulated HSP90 surface expression and reduced its secretion without altering HSP90 gene expression and intracytoplasmic protein levels. Pretreatment of HUVEC with 7,8‐DHMC prevented H2O2‐induced alterations of HSP90 cellular distribution and secretion. Our results suggest that the strong oxidative conditions of atherosclerotic plaques promote the upregulation of HSP90 surface expression on endothelial cells, thus rendering the protein a possible target of autoimmune reactions. The antioxidant 7,8‐DHMC, by preventing oxidative‐stress‐triggered HSP90 surface upregulation, may be useful to counteract possible autoreactive reactions to HSP90.
19 December 2017 in Journal of Immunology Research
Pregnancy problems are common in patients with rheumatic disease; indeed, autoimmune disorders and autoantibodies can affect pregnancy progress and lead to maternal complications. Recent studies have highlighted a close association between HMGB1, chronic inflammation, and autoimmune diseases. Thus, in this investigation, we analyzed serum levels of HMGB1, an alarmin which plays a pivotal role in inducing and enhancing immune cell function. Sera from 30 patients with antiphospholipid syndrome (11 primary and 19 secondary APS), 35 subjects with pregnancy morbidity, and 30 healthy women were analysed for HMGB1 and its putative receptor RAGE (sRAGE) by Western blot and for TNF-α by ELISA. Results revealed that APS patients showed significantly increased serum levels of HMGB1, sRAGE, and the proinflammatory cytokine TNF-α, as compared to healthy women. However, also, the pregnancy morbidity subjects showed significantly increased levels of HMGB1 and sRAGE as well as TNF-α compared to healthy women. Our findings suggest that in subjects with pregnancy morbidity, including obstetric APS, elevated levels of HMGB1/sRAGE may represent an alarm signal, indicating an increase of proinflammatory triggers. Further studies are needed to evaluate the role of HMGB1/sRAGE as a possible tool to evaluate the risk stratification of adverse pregnancy outcomes.
26 December 2021 in Journal of Thrombosis and Haemostasis
Cerebrovascular events (CE) are one of the most common and severe events in antiphospholipid syndrome (APS), a condition characterized by thrombosis and circulating anti-phospholipid antibodies (aPL). Seronegative APS (SN-APS) refers to a group of patients with clinical features of APS but persistently negative tests for “criteria aPL”: anti-cardiolipin antibodies (aCL) and anti-β2glycoprotein I antibodies detected by enzyme-linked immunosorbent assay (ELISA), and the lupus anticoagulant detected by clotting assays. We report a series of five cases of SN-APS in young or middle-aged patients who tested positive for “non-criteria” aPL. We retrospectively collected cases of SN-APS patients who experienced CE without an identified cause despite an extensive diagnostic work-up and tested negative for criteria aPL. All the patient sera were tested for aCL by immunostaining on thin-layer chromatography (TLC) and anti-vimentin/cardiolipin (aCL/Vim) by ELISA. We identified five cases of female patients aged 21 to 58 years, evaluated at the Rheumatology Unit and/ or Stroke Unit/Emergency Department of the Sapienza University Hospital of Rome, “Policlinico Umberto I”. All patients presented a clinical history suggestive of APS. All the patients tested positive for aCL by TLC-immunostaining, and one patient was positive for aCL/Vim. In young or middle-aged patients with cryptogenic CE and a clinical history suggestive of APS, the use of new diagnostic tools for identifying aPL, if validated in future studies, could represent an important step in the prompt diagnosis of APS.
Neuroglobin (Ngb) is a nerve hemeprotein that acts as a neuroprotectant against multiple brain injuries, including oxidative stress and β-amyloid toxicity. Besides inhibiting apoptosis and scavenging ROS/RNS, Ngb overexpression promotes autophagy, a highly conserved catabolic process essential for maintaining cellular homeostasis under both basal and stress conditions. Although Ngb upregulation has proven effective in animal models of neurological diseases, its effects have not yet been studied in three-dimensional (3D) cell cultures, which better mimic in vivo tissue architecture than monolayers. Therefore, in the present work we developed a simple yet reliable 3D model of Ngb overexpression using human SH-SY5Y neuroblastoma cells and examined its response to 1-methyl-4-phenylpyridinium (MPP+), a well-established in vitro model of Parkinson's disease (PD)-related neurodegeneration. Control and Ngb-overexpressing spheroids were generated using the hanging drop method. Ngb overexpression decreased MPP+ -induced ROS production and cell death, thus validating our 3D model. Additionally, biochemical fractionation and Thioflavin-S staining showed that Ngb upregulation reduces MPP+ -induced impairment of autophagy and amyloid accumulation, key pathological features of neurodegeneration. Overall, our findings emphasize the importance of 3D cultures for studying Ngb-mediated neuroprotection and suggest that Ngb upregulation may prevent the disruption of neuronal proteostasis under neurotoxic stress.